Melanoma dışı deri kanserlerinin nüks oranları: 11 yıllık retrospektif analiz

Bazal hücreli ve skuamoz hücreli deri kanserlerinde, tümör hücreleri genelde makroskobik olarak gördüğümüz sınırdan daha ileriye yayılmış olduğu için, cerrahi eksizyon yapılırken, lezyonla birlikte bir miktar sağlam deri de eksize edilir. Kliniğimizde bazal hücreli kanserler 3-5 mm, skuamoz hücreli kanserler ise 4-6 mm sağlam deri dokusu ile birlikte eksize edilmektedir. Ocak 1994-Ocak 2005 tarihleri arasında servisimize başvuran; melanoma dışı deri kanseri tanısı konularak ayaktan lokal anastezi altında tedavi edilen ve takibe alınan 516 hasta retrospektif olarak değerlendirildi ve rekürrens oranları ortaya kondu. Melanoma dışı deri kanseri tanısı konulan 516 olgunun 378'i (%73,2) bazal hücreli kanser, 138'i (%26,8) skuamoz hücreli kanser idi. 33 bazal hücreli kanser olgusunda (%8,7) ve 10 skuamoz hücreli kanser olgusunda (%7,2) rekürrens izlendi. Rekürrens gözlenen bazal hücreli kanserlerin tamamı (% 100), skuamoz hücreli kanserlerin ise 8 tanesi (%80) baş boyun bölgesinde lokalize idi. Elde edilen rekürrens oranları literatürde belirtilenlere göre yüksektir. Bu çalışmanın sonuçları, eksizyon sınırlarının kozmetik ve fonksiyonel kaygılar gibi çeşitli nedenlerle dar tutulmasının kanser rekürrensini artırdığını düşündürmektedir.

The recurrence frequency of nonmelanotic skin cancers: A retrospective analysis over 11 years

Background and Design.- Surgical excision of basal cell and squamous cell carcinoma includes a margin of healthy skin, because the microscopic margin is often considered to extend beyond the macroscopic margin. According to our general clinical principals, we excise the majority of basal cell carcinomas with a 3-5 mm, and squamous cell carcinomas with 4-6 mm margin of skin that appears clinically healthy with local anesthesia. Results.- This retrospective study of 516 patients treated surgically for primary nonmelanotic skin cancer was conducted from January 1994 to January 2005 and frequency of recurrence was defined. The sum of the patients with basal cell carcinoma was 378 (73.2%), and squomous cell carcinoma was 138 (26.8%). The number of the recurrence was 33 with basal cell carcinoma and 10 with squamous cell carcinoma. All of the recurrent basal cell carcinomas and the 8 (80%) of recurrent squamous cell carcinomas were at the head and neck region. The frequency of recurrence is higher than the literature. Conclusion.- Results of this study suggest that reduced excision margins anyway increased recurrence rate of tumor.

___

  • 1. Ceylan C, Öztürk G, Alper S. Non-melanoma skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinicopathological characteristics. J Dermatol. 2003; 30: 123.
  • 2. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003; 112: 57.
  • 3. Pascal RR, Hobby LW, Lattes R, Crikelair GF. Prognosis of incompletely excised versus completely excised basal cell carcinoma. Plas Reconstr Surg 1968; 41: 328.
  • 4. Gooding CA, White G, Yatsuhashi M. Significance of marginal extension in excised basal cell carcinoma. N Engl J Med 1965; 273: 923.
  • 5. Pearl RM, McAllister H, Pruzansky J. An economic analysis of health-care reform and its implications for plastic surgery. Plast Reconstr Surg 1997; 99: 1.
  • 6. Epstein E. How accurate is the visual assessment of basal carcinoma margins? Br J Dermatol 1973; 89: 37.
  • 7. Burg G, Hirsch RD, Konz B, Braun Falco O. Histographic survey: Accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg 1975; 1: 21.
  • 8. Choo R, Woo T, Assaad D, Antonyshyn O, Barnes EA, McKenzie D, Fialkoy J, Bren D, Mamedov A. What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers? Int J Radiat Oncol Biol Phys. 2005; 62: 1096.
  • 9. Koplin L, Zarem HA. Recurrent basal cell carcinoma:A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. Plast Reconstr Surg 1980; 65: 656.
  • 10. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27: 241.
  • 11. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol 1990; 23: 1118.
  • 12. Tirelioğlu S, Özgenel GY, Filiz G, Özbek S, Kahveci R, Akın S, Özcan M. 576 bazal hücreli kanser olgusunun retrospektif analizi. Türk Plast Rekonstr Est Cer Derg 2004; 12: 18.